Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IVM--the first choice for IVF in Italy.

M B Dal Canto1, M Mignini Renzini, F Brambillasca

  • 1BIOGENESI Reproductive Medicine Centre, Istituti Clinici Zucchi, V. Zucchi, 24-Monza, Italy. biogenesi.zucchi@grupposandonato.it

Reproductive Biomedicine Online
|August 10, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test of Lepton Flavor Universality with B_{s}^{0}→ϕℓ^{+}ℓ^{-} Decays.

Physical review letters·2025
Same author

Observation of the Open-Charm Tetraquark Candidate T_{cs0}^{*}(2870)^{0} in the B^{-}→D^{-}D^{0}K_{S}^{0} Decay.

Physical review letters·2025
Same author

Study of Λ_{b}^{0} and Ξ_{b}^{0} Decays to Λh^{+}h^{'-} and Evidence for CP Violation in Λ_{b}^{0}→ΛK^{+}K^{-} Decays.

Physical review letters·2025
Same author

First Evidence for Direct CP Violation in Beauty to Charmonium Decays.

Physical review letters·2025
Same author

First Determination of the Spin-Parity of Ξ_{c}(3055)^{+,0} Baryons.

Physical review letters·2025
Same author

Measurement of the Branching Fraction Ratios R(D^{+}) and R(D^{*+}) Using Muonic τ Decays.

Physical review letters·2025

Italy's 2004 assisted reproduction law limits oocytes and embryo cryopreservation, driving innovation. In-vitro maturation (IVM) offers a successful, cost-effective alternative to conventional IVF, reducing risks and drug side effects.

Area of Science:

  • Reproductive Medicine
  • Embryology
  • In Vitro Fertilization

Background:

  • Italian assisted reproduction law (March 2004) restricts oocyte usage (max 3 per cycle) and prohibits embryo/pre-zygote selection and cryopreservation.
  • These restrictions reduce success rates of conventional IVF and necessitate new therapeutic strategies.
  • In-vitro maturation (IVM) of oocytes emerges as a viable alternative, aligning with new regulatory requirements.

Purpose of the Study:

  • To evaluate the efficacy and safety of In-vitro maturation (IVM) as an alternative to conventional IVF.
  • To assess IVM's potential to overcome limitations imposed by Italian assisted reproduction law.
  • To determine if IVM can offer high success rates with reduced risks and costs.

Main Methods:

  • Implementation of an In-vitro maturation (IVM) protocol in an IVF center.

Related Experiment Videos

  • Monitoring of oocyte maturation, fertilization, embryo transfer rates, and pregnancy outcomes.
  • Comparison of IVM outcomes with expected results from conventional IVF under the new law.

    • Main Results:

    • IVM technique demonstrated significant success over one year of application.
    • Achieved favorable maturation and fertilization rates.
    • Reported successful embryo transfers, pregnancies, and healthy babies born.

    Conclusions:

    • In-vitro maturation (IVM) is a promising alternative to conventional IVF, especially under restrictive regulations.
    • IVM avoids ovarian stimulation, reducing side effects like ovarian hyperstimulation syndrome and lowering procedure costs.
    • The IVM protocol facilitates spare oocyte handling and offers a high chance of success with minimal risks.